Innovative cancer biomarker technologies
At IBM it’s our objective to help bring solutions to market that improve health outcomes for patients. Working with Vivolution, our Commercialisation Partner is critical to achieve this. Vivolution work with qualified scale-up’s continue to develop and support the relationship with IBM and Meridan IT. This collaboration showcases the potential of IBM’s platforms, including IBM PowerAI Vision, to support the rapid development and implementation of disruptive precision medicine innovation and resonates strongly with our focus on improving the scope & quality of advanced personalised healthcare.Andreas Haimbock-Tichy Director; Health & Life Sciences.
Spearhead and facilitate a Corporate Innovation Partnership with the IBM Partner Cloud to identify emerging technology scale-ups: -
IBM is one of the largest IT providers in the world with operations & clients in more than 170 countries: